New diabetes clinical trial: A Randomized, Placebo-controlled, Double-blinded Cross-over Study of the Pharmacologic Action of a GPR119 Agonist

Published on: June 16, 2020 at 09:30PM
Condition:   Diabetes Mellitus, Type 1
Interventions:   Device: Continuous glucose monitoring (CGM);   Other: Standard mixed meal challenge;   Other: Hyperinsulinemic euglycemic-hypoglycemic clamp;   Drug: Placebo;   Drug: Study Medication (MBX-2982)
Sponsor:   Translational Research Institute for Metabolism and Diabetes, Florida
Not yet recruiting
https://ift.tt/2Y4oL3d